T. Rowe Price Investment Management, Inc. Haemonetics Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,850,637 shares of HAE stock, worth $225 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
2,850,637
Previous 1,642,941
73.51%
Holding current value
$225 Million
Previous $136 Million
68.58%
% of portfolio
0.14%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding HAE
# of Institutions
332Shares Held
53.8MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$470 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$408 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$350 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$331 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$318 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.05B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...